Sung‐Hoon Jung

3.0k total citations
161 papers, 2.0k citations indexed

About

Sung‐Hoon Jung is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Sung‐Hoon Jung has authored 161 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 63 papers in Oncology and 49 papers in Molecular Biology. Recurrent topics in Sung‐Hoon Jung's work include Multiple Myeloma Research and Treatments (61 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunotherapy and Immune Responses (24 papers). Sung‐Hoon Jung is often cited by papers focused on Multiple Myeloma Research and Treatments (61 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunotherapy and Immune Responses (24 papers). Sung‐Hoon Jung collaborates with scholars based in South Korea, Canada and United States. Sung‐Hoon Jung's co-authors include Je‐Jung Lee, Hyeoung‐Joon Kim, Jae‐Sook Ahn, Deok‐Hwan Yang, Manh-Cuong Vo, Hyunju Lee, Deok‐Hwan Yang, J. W. Kugler, David L. Ahmann and Roscoe F. Morton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sung‐Hoon Jung

146 papers receiving 2.0k citations

Peers

Sung‐Hoon Jung
Jacques‐Olivier Bay France
Imad A. Tabbara United States
Philipp B. Staber Austria
Diane van der Woude Netherlands
Jan Leipe Germany
Gregor Hoermann Austria
Robert Corringham United States
David T. Yang United States
Jacques‐Olivier Bay France
Sung‐Hoon Jung
Citations per year, relative to Sung‐Hoon Jung Sung‐Hoon Jung (= 1×) peers Jacques‐Olivier Bay

Countries citing papers authored by Sung‐Hoon Jung

Since Specialization
Citations

This map shows the geographic impact of Sung‐Hoon Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Hoon Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Hoon Jung more than expected).

Fields of papers citing papers by Sung‐Hoon Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Hoon Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Hoon Jung. The network helps show where Sung‐Hoon Jung may publish in the future.

Co-authorship network of co-authors of Sung‐Hoon Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Sung‐Hoon Jung. A scholar is included among the top collaborators of Sung‐Hoon Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung‐Hoon Jung. Sung‐Hoon Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vo, Manh-Cuong, Mihee Kim, Ga‐Young Song, et al.. (2025). Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cells. Translational Oncology. 60. 102475–102475. 1 indexed citations
3.
Song, Ga‐Young, Seo-Yeon Ahn, Sung‐Hoon Jung, et al.. (2025). Prognostic Value of 18F-FDG PET in Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine. 50(4). 281–288. 1 indexed citations
4.
Kim, Mihee, Je‐Jung Lee, Chang‐Ki Min, et al.. (2023). Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). Annals of Hematology. 102(8). 2233–2240. 1 indexed citations
5.
Vo, Manh-Cuong, Seo-Yeon Ahn, Mihee Kim, et al.. (2022). Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma. Translational Oncology. 20. 101413–101413. 6 indexed citations
6.
Jung, Sung‐Hoon, Kihyun Kım, Sang Eun Yoon, et al.. (2022). Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party. Blood Cancer Journal. 12(11). 157–157. 6 indexed citations
7.
Kim, Tae‐Hyung, Jae-Sook Ahn, Meong Hi Son, et al.. (2022). Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms. Leukemia Research. 118. 106858–106858. 1 indexed citations
8.
Vo, Manh-Cuong, Jin Young Kim, Chulhong Kim, et al.. (2021). Pilot Study: Quantitative Photoacoustic Evaluation of Peripheral Vascular Dynamics Induced by Carfilzomib In Vivo. Sensors. 21(3). 836–836. 5 indexed citations
9.
Cho, Hee Jeong, Dong Won Baek, Ju-Hyung Kim, et al.. (2021). Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline. Clinical Lymphoma Myeloma & Leukemia. 22(2). 113–120. 1 indexed citations
10.
Baek, Dong Won, Dae Young Kim, Sang Kyun Sohn, et al.. (2021). Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study. The Korean Journal of Internal Medicine. 36(6). 1471–1485. 3 indexed citations
11.
Jung, Sung‐Hoon, Young Rok, Dae Sik Kim, et al.. (2020). Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia. Yonsei Medical Journal. 61(6). 452–452.
12.
Kim, Tae‐Hyung, Joon Ho Moon, Jae-Sook Ahn, et al.. (2018). Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse. Blood. 132(15). 1604–1613. 77 indexed citations
13.
Vo, Manh-Cuong, Sung‐Hoon Jung, Hyunju Lee, et al.. (2018). Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma. Frontiers in Immunology. 9. 1370–1370. 34 indexed citations
14.
15.
16.
Park, Tae Ju, Yang Hyun Cho, Ho Seok Chung, et al.. (2016). Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer. SpringerPlus. 5(1). 1889–1889. 24 indexed citations
17.
Jung, Sung‐Hoon, Jae‐Sook Ahn, Yeo-Kyeoung Kim, et al.. (2016). Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients. Journal of Korean Medical Science. 31(7). 1160–1160. 7 indexed citations
18.
Jung, Sung‐Hoon, Hee Kyung Kim, Ho‐Cheol Kang, et al.. (2016). Secondary Adrenal Insufficiency Is Associated with Poor Survival Outcomes in Multiple Myeloma. Blood. 128(22). 5631–5631. 1 indexed citations
19.
Oh, Jung Hwan, et al.. (2014). Slow Overmethylation of Housekeeping Genes in the Body Mucosa Is Associated with the Risk for Gastric Cancer. Cancer Prevention Research. 7(6). 585–595. 15 indexed citations
20.
Kim, Jin‐Hyuk, Byung‐Ho Kim, Tae-Hee Lee, et al.. (2003). A Case of Hepatocellular Carcinoma Presenting with Four Paraneoplastic Syndromes such as Hypercholesterolemia, Hypoglycemia, Hypercalcemia, and Erythrocytosis. Korean Journal of Gastroenterology. 41(4). 316–320. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques‐Olivier Bay Breakdown of academic impact, for papers by Imad A. Tabbara Breakdown of academic impact, for papers by Philipp B. Staber Breakdown of academic impact, for papers by Diane van der Woude Breakdown of academic impact, for papers by Jan Leipe Breakdown of academic impact, for papers by Gregor Hoermann Breakdown of academic impact, for papers by Robert Corringham Breakdown of academic impact, for papers by David T. Yang
Rankless by CCL
2026